{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:06:48Z","timestamp":1780067208669,"version":"3.54.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007374","name":"Universidade Federal De Minas Gerais","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007374","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anaplastic large cell lymphoma (ALCL) is contained within a larger category of aggressive mature T-cell lymphomas. Their subclassification relies on the presence or absence of\n                    <jats:italic>Anaplastic Lymphoma Kinase<\/jats:italic>\n                    (ALK) gene fusions and other molecular alterations. Cases in the head and neck and mouth are uncommon. The aim of this manuscript is to describe the clinicopathological and immunohistochemical features of a series of anaplastic large cell lymphoma (ALCL) affecting the oral cavity. Three cases are included in this series, all of them affecting male patients, with a mean age of 27.7\u00a0years old. Concomitant involvement of the oral cavity and lymph nodes was known to occur in two cases, while cutaneous lesions were not recorded in any patient. The neoplasms more often presented as solitary or multiple painful swellings in the gingiva. All cases were positive for CD30 expression, and the two cases investigated for CD3 were negative. ALK protein was expressed in two cases, and it was negative in one case. EBER was negative in the two cases investigated. One patient was known to decease despite chemotherapy. In conclusion, oral manifestations of ALCL are very rare and more commonly represent a disseminated disease.\n                  <\/jats:p>","DOI":"10.1007\/s12308-026-00703-8","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:58:56Z","timestamp":1780066736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral manifestations of anaplastic large cell lymphoma: clinicopathological features and main immunophenotypic findings of 3 cases"],"prefix":"10.1007","volume":"19","author":[{"given":"Carla Isabelly","family":"Rodrigues-Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Assis","family":"de Siqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinthia Veronica Bard\u00e1lez L\u00f3pez","family":"de C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel Arteaga","family":"Legarrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Tieghi","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geovana Martins","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Cavalcanti","family":"da Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lder Ant\u00f4nio Rebelo","family":"Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Delgado-Aza\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Rossi Assis","family":"de Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Agustin","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Luiz","family":"Coracin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Paiva","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"703_CR1","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3390\/cancers14071650","volume":"14","author":"XR Zhang","year":"2022","unstructured":"Zhang XR, Chien PN, Nam SY, Heo CY (2022) Anaplastic large cell lymphoma: molecular pathogenesis and treatment. Cancers (Basel) 14:1650","journal-title":"Cancers (Basel)"},{"key":"703_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","volume":"66","author":"H Stein","year":"1985","unstructured":"Stein H, Mason DY, Gerdes J, O\u2019Connor N, Wainscoat J, Pallesen G et al (1985) The expression of the Hodgkin\u2019s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848\u2013858","journal-title":"Blood"},{"key":"703_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumors: lymhpoid neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"703_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/hon.3074","volume":"40","author":"C Chiattone","year":"2022","unstructured":"Chiattone C, Civallero M, Fischer T, Miranda E, Manni M, Zing NPC (2022) Characteristics and clinical outcomes of patients with ALK-positive Anaplastic Large Cell Lymphoma: a report from the prospective international T-cell Lymphoma Project. Hematol Oncol 40:953\u2013961","journal-title":"Hematol Oncol"},{"key":"703_CR5","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1182\/blood.V84.11.3648.bloodjournal84113648","volume":"84","author":"M Shiota","year":"1994","unstructured":"Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M et al (1994) Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648\u20133652","journal-title":"Blood"},{"key":"703_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12308-024-00585-8","volume":"17","author":"AD Attygalle","year":"2024","unstructured":"Attygalle AD, Chan JKC, Coupland SE, Du MQ, Ferry JA, de Jong D et al (2024) What is new in the 5th edition of the World Health Organization classification of mature B and T\/NK cell tumors and stromal neoplasms? J Hematopathol 17:71\u201389","journal-title":"J Hematopathol"},{"key":"703_CR7","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140:1229\u20131253","journal-title":"Blood"},{"key":"703_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1099265","volume":"12","author":"C Murga-Zamalloa","year":"2022","unstructured":"Murga-Zamalloa C, Inamdar K (2022) Classification and challenges in the histopathological diagnosis of peripheral T-cell lymphomas, emphasis on the WHO-HAEM5 updates. Front Oncol 12:1099265","journal-title":"Front Oncol"},{"key":"703_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1241532","volume":"13","author":"R Wu","year":"2023","unstructured":"Wu R, Lim MS (2023) Updates in pathobiological aspects of Anaplastic Large Cell Lymphoma. Front Oncol 13:1241532","journal-title":"Front Oncol"},{"key":"703_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","volume":"40","author":"RL King","year":"2016","unstructured":"King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH et al (2016) Morphologic features of ALK negative Anaplastic Large Cell Lymphomas with DUSP22 rearrangements. Am J Surg Pathol 40:36\u201343","journal-title":"Am J Surg Pathol"},{"key":"703_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/modpathol.2012.38","volume":"25","author":"AP Sciallis","year":"2012","unstructured":"Sciallis AP, Law ME, Inwards DJ et al (2012) Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol 25:983\u2013992","journal-title":"Mod Pathol"},{"key":"703_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s12105-020-01176-6","volume":"14","author":"BAB Andrade","year":"2020","unstructured":"Andrade BAB, Fontes MD, Roza ALOC, Vargas PA, Agostini M, Canedo NHS (2020) Anaplastic Large Cell Lymphoma with oral manifestation: a series of four cases and literature review. Head Neck Pathol 14:991\u20131000","journal-title":"Head Neck Pathol"},{"issue":"3","key":"703_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11899-024-00727-w","volume":"19","author":"JJ Chen","year":"2024","unstructured":"Chen JJ, Tokumori FC, Del Guzzo C, Kim J, Ruan J (2024) Update on T-Cell lymphoma epidemiology. Curr Hematol Malig Rep 19(3):93\u2013103","journal-title":"Curr Hematol Malig Rep"},{"key":"703_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5581\/1516-8484.20120013","volume":"34","author":"M Bellei","year":"2012","unstructured":"Bellei M, Chiattone CS, Luminari S, Pesce EA, Cabrera ME, Souza CA (2012) T-cell lymphomas in South America and Europe. Rev Bras Hematol Hemoter 34:42\u201347","journal-title":"Rev Bras Hematol Hemoter"},{"key":"703_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1182\/blood-2023-187254","volume":"142","author":"T Fischer","year":"2023","unstructured":"Fischer T, Idrobo H, Pavlovsky A, Castro D, Beltran B, Enriquez DJ, Vasquez JF et al (2023) Hodgkin lymphomas and T\/Nk cell lymphomas: clinical and epidemiological. Blood 142:186\u2013189","journal-title":"Blood"},{"issue":"7","key":"703_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11071220","volume":"11","author":"SL Chen","year":"2021","unstructured":"Chen SL, Chan KC (2021) Anaplastic lymphoma kinase- and CD30-positive anaplastic large-cell lymphoma of the external auditory canal. Diagnostics Basel 11(7):1220","journal-title":"Diagnostics Basel"},{"key":"703_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.htct.2023.09.646","volume":"45","author":"CS Chiattone","year":"2023","unstructured":"Chiattone CS, Miranda E, Medina SS, Baptista RLR, Pereira J, Brasil SAB (2023) An updated of peripheral T-Cell lymphoma patients registry of T-Cell Brazil project: a prospective cohort analysis. Hematol Transfus Cell Ther 45:S1\u2013S1006","journal-title":"Hematol Transfus Cell Ther"},{"issue":"3","key":"703_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3109\/10428190903572201","volume":"51","author":"K Perez","year":"2010","unstructured":"Perez K, Castillo J, Dezube BJ, Pantanowitz L (2010) Human immunodeficiency virus-associated anaplastic large cell lymphoma. Leuk Lymphoma 51(3):430\u2013438","journal-title":"Leuk Lymphoma"},{"key":"703_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.12703\/r\/12-21","volume":"12","author":"MJ Gromowsky","year":"2023","unstructured":"Gromowsky MJ, D\u2019Angelo CR, Lunning MA, Armitage JO (2023) ALK-positive anaplastic large cell lymphoma in adults. Fac Rev 12:21","journal-title":"Fac Rev"},{"key":"703_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.humpath.2017.01.003","volume":"64","author":"X Wang","year":"2017","unstructured":"Wang X, Boddicker RL, Dasari S, Sidhu JS, Kadin ME, Macon WR et al (2017) Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. Hum Pathol 64:19\u201327","journal-title":"Hum Pathol"},{"issue":"3","key":"703_CR21","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1111\/bjh.15860","volume":"186","author":"G Hapgood","year":"2019","unstructured":"Hapgood G, Ben-Neriah S, Mottok A, Lee DG, Robert K, Villa D et al (2019) Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma. Br J Haematol 186(3):e28\u2013e31","journal-title":"Br J Haematol"},{"issue":"4","key":"703_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","volume":"130","author":"MB Pedersen","year":"2017","unstructured":"Pedersen MB, Hamilton-Dutoit SJ, Bendix K, Ketterling RP, Bedroske PP, Luoma IM (2017) DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study. Blood 130(4):554\u2013557","journal-title":"Blood"},{"issue":"9","key":"703_CR23","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA et al (2014) ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124(9):1473\u20131480","journal-title":"Blood"},{"issue":"1","key":"703_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","volume":"126","author":"G Hapgood","year":"2015","unstructured":"Hapgood G, Savage KJ (2015) The biology and management of systemic anaplastic large cell lymphoma. Blood 126(1):17\u201325","journal-title":"Blood"},{"issue":"2","key":"703_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/bjh.15145","volume":"181","author":"KA Nguyen","year":"2018","unstructured":"Nguyen KA, Su C, Bai HX, Zhang Z, Xiao R, Karakousis G et al (2018) Disease site as a determinant of survival outcome in patients with systemic anaplastic lymphoma kinase positive anaplastic large cell lymphoma with extranodal involvement: an analysis of 1306 cases from the US National Cancer Database. Br J Haematol 181(2):196\u2013204","journal-title":"Br J Haematol"},{"issue":"6","key":"703_CR26","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1177\/014556131509400617","volume":"94","author":"GR Dion","year":"2015","unstructured":"Dion GR, Packer MD (2015) Anaplastic large-cell lymphoma presenting as a nasopharyngeal mass and cervical lymphadenopathy. Ear Nose Throat J 94(6):E26\u2013E29","journal-title":"Ear Nose Throat J"},{"key":"703_CR27","doi-asserted-by":"publisher","first-page":"688.e13","DOI":"10.1016\/j.wneu.2015.11.020","volume":"88","author":"CY Yeung","year":"2016","unstructured":"Yeung CY, Hong KT, Chiang CP, Chen YH, Ma HI, Tsai TH (2016) Anaplastic lymphoma kinase negative anaplastic large cell lymphoma manifesting as a scalp hematoma after an acute head injury-a case report and literature review. World Neurosurg 88:688.e13-688.e16","journal-title":"World Neurosurg"},{"key":"703_CR28","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.tripleo.2008.05.037","volume":"106","author":"N Matsumoto","year":"2008","unstructured":"Matsumoto N, Ohki H, Mukae S, Amano Y, Harada D, Nishimura S et al (2008) Anaplastic large cell lymphoma in gingiva: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:e29-34","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"703_CR29","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.oooo.2012.04.010","volume":"115","author":"A Grandhi","year":"2013","unstructured":"Grandhi A, Boros AL, Berardo N, Reich RF, Freedman PD (2013) Two cases of CD30+, anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with oral manifestations. Oral Surg Oral Med Oral Pathol Oral Radiol 115:e41\u2013e47","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"703_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0266-4356(97)90563-5","volume":"35","author":"A Chandu","year":"1997","unstructured":"Chandu A, Mitchell DA, Corrigan AM (1997) Cutaneous CD30 positive large T cell lymphoma of the upper lip: a rare presentation. Br J Oral Maxillofac Surg 35:193\u2013195","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"2","key":"703_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.critrevonc.2012.02.005","volume":"83","author":"AJ Ferreri","year":"2012","unstructured":"Ferreri AJ, Govi S, Pileri SA, Savage KJ (2012) Anaplastic large cell lymphoma, ALK-positive. Crit Rev Oncol Hematol 83(2):293\u2013302","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"703_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11899-018-0436-z","volume":"13","author":"K Vu","year":"2018","unstructured":"Vu K, Ai W (2018) Update on the treatment of anaplastic large cell lymphoma. Curr Hematol Malig Rep 13(2):135\u2013141","journal-title":"Curr Hematol Malig Rep"},{"issue":"5","key":"703_CR33","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41375-020-01093-1","volume":"35","author":"C Lobello","year":"2021","unstructured":"Lobello C, Tichy B, Bystry V, Radova L, Filip D, Mraz M (2021) STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemia 35(5):1500\u20131505","journal-title":"Leukemia"},{"issue":"2","key":"703_CR34","volume":"106","author":"CG Passerini","year":"2014","unstructured":"Passerini CG, Farina F, Stasia A, Grosso F, Mologni L, Pulsoni A et al (2014) Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients. J Natl Cancer Inst 106(2):djt378","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00703-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:58:57Z","timestamp":1780066737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00703-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["703"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00703-8","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"26"}}